Back to search results

Virtual Rehabilitation for Young People After Hematopoietic Cell Transplant

This study is looking at a virtual exercise and rehabilitation program for young people aged 8 to 23 who have had a hematopoietic cell transplant (HCT), also known as a bone marrow transplant. Many HCT patients, especially those with chronic GVHD (graft-versus-host disease), face challenges getting to in-person rehabilitation. This program aims to make exercise more accessible by offering two 30-minute virtual sessions per week for 12 weeks, focusing on aerobic and stretching exercises. The main goals are to see how well participants stick with the program (adherence rate) and if the program is practical to use (feasibility). The study hopes to improve physical functioning and quality of life for these patients. It is currently unclear if the study is recruiting, but it plans to enroll 40 participants.

Study design
This is an interventional study planning to enroll 40 participants. The study does not specify a phase.
What's involved
You would participate in two 30-minute virtual exercise sessions per week for 12 weeks. If you are 8-14 years old, a caregiver needs to help during sessions. You also need access to devices and a reliable internet connection.
Compensation
Not stated in the trial record.
Follow-up
The feasibility of the program will be measured for up to 4 years after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05943964

Virtual Rehabilitation in HCT

Recruiting
NAAges 8–23InterventionalSupportive care
Emory University
~40 participants
Updated 2025-09-19 on ClinicalTrials.gov
What's tested:Virtual exercise and rehabilitation program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence Rate
Measured over Throughout the intervention (up to 16 weeks)
+1 more outcome measured

Conditions

Hematopoietic Cell Transplant

Explore related trials

Chronic Graft Versus Host DiseaseHematopoietic Cell Transplantation

Where it's being run

1 sites across 1 states
Georgia1

Study leadership

  • Muna Qayed, MD, MsCR · PRINCIPAL_INVESTIGATOR · Emory University

Who to contact

Muna Qayed, MD, MsCR
[email protected]
(404) 785-1112
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Recipients between the ages of 8 and 23 years ≥100 days post allogeneic HCT.
Patients 8-14 years old should have a caregiver willing to assist with the implementation of the exercises during the session
Patients should have access to devices and a reliable internet connection.
Patients should be cleared for exercise by their physician
Patients are eligible to participate regardless of underlying diagnosis, preparative regimen, or graft source.

Exclusion

Any physical impediment to exercise as evaluated by the treating physician.
Non-English-speaking patients (due to a lack of available interpreters through the telemedicine platform).

What this trial measures

  • Adherence RateThroughout the intervention (up to 16 weeks)

    Percentage of sessions completed per participant. A log will be kept to track the sessions completed by participants during the study participation

  • Feasibility of the rehabilitation programUp to 4 years

    Percentage of patients completing ≥75% of sessions